INTRODUCTION
Cystic fibrosis transmembrane conductance regulator (CFTR) is a multidomain, polytopic membrane protein that belongs to the ATP-binding cassette (ABC) transporter C class superfamily (Riordan, 2008) . CFTR consists of two membrane-spanning domains (MSD1, MSD2) with four cytosolic loops (CL1-4) and three cytosolic domains: a regulatory (R) and two nucleotidebinding domains (NBD1, NBD2). Deletion of F508 (DF508) in the NBD1 is a cystic fibrosis (CF)-causing mutation found in at least one allele of 90% of patients (http://www.genet.sickkids. on.ca/cftr). This mutation diminishes the intrinsically low (20%-40%) folding efficiency of CFTR to $0.4% (Cheng et al., 1990; Pedemonte et al., 2005) and results in ubiquitin (Ub)-dependent endoplasmic reticulum (ER)-associated degradation, thereby compromising the channel plasma membrane (PM) expression (Riordan, 2008) . Impaired gating kinetics and reduced metabolic stability of the mutant further exacerbates the CFTR loss-offunction phenotype (Dalemans et al., 1991; Sharma et al., 2004) .
Low temperature, chemical chaperones, and second-site suppressor mutations in the NBD1 or at the NBD1-MSD2 interface can restore the PM functional expression of DF508 CFTR up to 15% of wild-type (WT) CFTR Denning et al., 1992; He et al., 2010; Loo et al., 2009 Loo et al., , 2010 Sato et al., 1996; Teem et al., 1993 Teem et al., , 1996 Thibodeau et al., 2010) . Comparable or poorer rescue efficiencies were achieved by small molecule correctors identified by high-throughput screens (HTSs) in vivo (Pedemonte et al., 2005; Robert et al., 2010; Sampson et al., 2011; Van Goor et al., 2006 and in silico (Kalid et al., 2010) . Despite intensive efforts, the available investigational corrector compound (VX-809) has similarly modest efficiency (Clancy et al., 2011) .
The original observation that DF508 NBD1 refolding is impaired and the domain has marginally defective thermodynamic stability (Qu and Thomas, 1996) is further elucidated by the observation of localized structural perturbation of the flexible surface loop of residues 509-511 in the crystal structures (Lewis et al., 2005 (Lewis et al., , 2010 Thibodeau et al., 2005) . Although these findings were consistent with the notion of formation of kinetically trapped folding intermediate(s) (Thibodeau et al., 2005) , it was recognized that the DF508 CFTR misfolding coincides with a global folding defect that affects the conformation of MSD1, MSD2, and NBD2 (Cui et al., 2007; Du and Lukacs, 2009; Du et al., 2005; Rosser et al., 2008) . Based on the predicted domain-swapped architecture of CFTR that manifests in the invariability of contacts between coupling helices of the CLs and NBDs from opposite halves in ABC exporters (Mornon et al., 2009; Serohijos et al., 2008a) (Figure 1A ), engineered Cys crosslinking confirmed that the F508 and its vicinity interface with the CL4 and CL1 of MSD2 and MSD1, respectively (Figure 1A) Serohijos et al., 2008a) . These contacts, similar to that of the NBD2-MSD1, are not detectable in nonnative, core-glycosylated WT and DF508 CFTR Serohijos et al., 2008a) , consistent with a possible role in domain assembly. Jointly, these observations along with the observations on CFTR-interdependent domain folding and misfolding helped to formulate the cooperative domain-folding model that invokes energetic/kinetic conformational domain-domain coupling as part of the CFTR co-and posttranslational folding (Du and Lukacs, 2009 ).
More recent results established that the DF508 mutation promotes the NBD1 thermal aggregation (Hoelen et al., 2010) and compromises the thermodynamic stability of the NBD1 containing three solubilizing (S) mutations or deletion of the regulatory insertion (DRI, residues 405-436) Wang et al., 2010) . The DF508-NBD1 folding energetic defect in the absence of second-site mutations and its contribution to DF508 CFTR global misfolding, however, are poorly defined. We hypothesized that both NBD1 interface topology and energetics are important determinants of CFTR domain assembly. Our results show that either NBD1 energetics or the NBD1-CL4 interface defect can instigate CFTR domain misassembly. Conversely, genetic suppression of either energetic or interface defects alone is insufficient to restore DF508 CFTR folding, processing, and function, whereas in combination they result in mature protein with properties similar to those of WT CFTR.
RESULTS

Thermodynamic Destabilization of Isolated NBD1
Variants by the DF508 Mutation To determine the DF508-induced NBD1 energetic defect, fulllength WT and DF508 human NBD1 variants (amino acids 389-678) with or without S and/or revertant (R) mutations were purified from E. coli as described (Lewis et al., 2005) . Both the R mutations (G550E, R553Q, and R555K) and S mutations (F409L, F429S, F433L, F494N, and H667R) could partially rescue the DF508 CFTR folding and functional defect (Lewis et al., 2005; Pissarra et al., 2008; Teem et al., 1993 Teem et al., , 1996 and were assumed to stabilize the domain either alone or in combinations (1S, 3S, R, R1S, and R4S; see Figure 1B ). The isolated NBD1s were >90%-95% pure and monomeric (see Figures S1A and S1B available online; data not shown). The secondary structure composition and TNP-ATP-binding affinity of WT-and DF508-NBD1 variants were comparable (Figures S1C and S1D; data not shown) Qu and Thomas, 1996; Stratford et al., 2007) .
The DF508 mutation reduced the apparent melting temperature (T m ) of the WT NBD1-1S from 41.8 C ± 0.2 C to 33.2 C ± 0.2 C (DT m z 8.6 C ± 0.2 C) (±standard error of the mean [SEM]), based on ellipticity, as well as Trp fluorescence and differential scanning fluorimetry (DSF) using different reporter dyes ( Figures 1C-1E , S1E, and S1F) (Niesen et al., 2007; Senisterra et al., 2008) . In the absence of second-site mutations, the WT and DF508 NBD1-0S thermal denaturation propensity was slightly increased (T m $39.8 C ± 0.2 C and $31.7 C ± 0.1 C, respectively) relative to NBD1-1S measured at 2.5 mM ATP ( Figures 1D and 1E ). Because the protein yield was limited ( Figure S1G ), only DSF scans could be performed on NBD1-0S.
The T m difference between the WT and DF508 NBD1 was similar (6 C-8 C) for 0S, 1S, 3S, R, and R4S and in DRI , as well as at reduced ATP concentration ( Figures 1E, S1H , and S1I). Thermal unfolding preceded domain aggregation for both WT and DF508-NBD1 (Extended Experimental Procedures; Figure S1J ). Assuming a reversible, twostate folding mechanism with slow aggregation of the unfolded form , we estimated the folding free energy (DG 0 ) based on the DSF data. Decreasing the temperature from 37 C to 20 C lowered the DG 0 of the DF508 and WT NBD1-0S from +1.8 to À4.2 kcal/mol and from À1.0 to À4.8 kcal/mol, respectively (Extended Results; Table S1 ). The DF508 decreased the midpoint urea denaturation concentration (D 0.5 ) of the WT NBD1 variants by $0.8-1 M at 1 mM ATP ( Figure S2E ). NBD1 fractional unfolding was calculated by extrapolation of the CD data due to the oligomerization/ aggregation propensity of partially unfolded DF508-NBD1 (Figures 1F and S2A-S2D; Extended Results) Wang et al., 2010) . The estimated DG 0 between the WT-and DF508-NBD1-1S and -3S was decreased by $2.4 and $1.4 kcal/mol, respectively, whereas the R1S and R4S mutation stabilized the DF508 by $1 and $1.6 kcal/mol at 20 C (Figure 1G ). Thermal unfolding analysis yielded comparable DG 0 differences between WT and DF508-NBD1-0S, -1S, and -3S (approximately À1.7, À1.6, and À2.3 kcal/mol, respectively; Extended Results; Table S1 ). Thus, thermal and chemical denaturation studies demonstrated the thermodynamic destabilization of the DF508 NBD1 with a single or no S mutation at 37 C ( Figure 2A ).
Kinetic Destabilization of NBD1 by the DF508 Mutation
To determine the unfolding energy barrier between the native and unfolded states, the rate of NBD1 unfolding was monitored as a function of urea concentration by CD spectroscopy ( Figures  2B, S2A , and S2B). The NBD1-1S initial unfolding kinetics exhibited monoexponential behavior and was found to be independent of protein concentration between 3 and 14 mM (data not shown). The DF508-NBD1-1S extrapolated unfolding rate in water (k u H20 ) was >30-fold (0.73 s À1 ) and $17-fold (0.04 s À1 ) faster than its WT counterpart at 20 C and 37 C, respectively ( Figures 2C and 2D ). The k u H20 at 37 C was determined by the extrapolation of k u H20 obtained at 16 C-30 C ( Figure S2F ). The unfolding activation energy (DG u z )
of the WT NBD1-1S was reduced in the DF508 from $5.0 ± 0.11 to $2.9 ± 0.04 kcal/mol (n = 6) at 20 C and from $1.8 to $0.2 kcal/mol at 37 C ( Figure S2G ; Table S1 ). In contrast the R1S and R4S mutations partially restored kinetic stability of the DF508 NBD1-1S by reducing the k u H20 $3-to 4-fold at 20 C ( Figure 2C ). Jointly, these results showed for the first time that the DF508 reduces both thermodynamic and kinetic components of the DF508-NBD1-1S energetic defect at 37 C, which could be reversed by second-site suppressor mutations. (Mornon et al., 2009 ). The hydrophobic cluster formed by F1068 and F1074 at the NBD1-CL4 interface by the CL4-coupling helix (dark blue) and F508 (green) is indicated in the inset. (B) R and S mutations are indicated in the crystal structure of the human NBD1 (PDB: 2BBO) (Lewis et al., 2010) . Lower panel depicts the combination of secondsite S and R mutations used. The increased conformational flexibility of the DF508-NBD1-1S was verified by a modest but significant enhancement in deuterium uptake, determined by hydrogen-deuterium exchange (HDX) mass spectrometry (MS) after 15 min incubation at 24 C, but not at 0 C ( Figure S3 ). Due to thermodynamic stabilization, the extent of HDX for DF508-NBD1-1S was profoundly reduced by the R1S mutation, consistent with the increased backbone dynamics of the DF508-NBD1-3S, localized to residues 509-511 (Lewis et al., 2010) .
The DF508 NBD1 Conformational Defect Is Recognizable by Protein Quality Control To ascertain that the DF508-NBD1 structural defect may serve as a degradation signal in vivo, the metabolic turnover of NBD1 fusion proteins was determined in prokaryotes and eukaryotes. The degradation rate of the DF508-NBD1-1S was $4-fold faster than the WT-NBD1-1S in E. coli at 37 C (data not shown). To examine the effect of NBD1 conformational stability on the ER export efficiency, NBD1s were tethered to the C-terminally truncated CD4 (CD4T-NBD1) ( Figure 3A ). The PM density of the chimeras was monitored by cell surface ELISA as a surrogate measure of ER export efficiency at comparable translational rates in COS7 cells at 37 C (Extended Results; Figures S4A-S4C; Du and Lukacs, 2009 ). The DF508 mutation decreased the PM expression of WT CD4T-NBD1 from 20% to 10% of CD4T, similar to that observed at the cellular expression level ( Figures 3B and 3C ). The DF508 mutation decreased the PM density of CD4T-NBD1 variants containing second-site mutations, whereas conformational stabilization by the R4S reversed the phenotype ( Figure 3C ). The low level of DF508 CD4T-NBD1-R1S expression could be attributed to the partially normalized unfolding kinetics of the domain ( Figure 2C ). Stabilization of WT NBD1 by second-site mutation, however, elevated the chimera PM expression from 20% to 60% ( Figure 3C ). These results in concert with the effect of F508E, F508R, F508G, F508S, F508D, and F508N mutations revealed that the CD4T-NBD1 PM density was proportional to the domain stability if the NBD1 T m was >38 C ( Figures 3D and S4D ). Chimeras containing NBD1s with T m <38 C exhibited %10% expression of CD4T in COS7 cells at 37 C ( Figure 3D ), consistent with the domain instability and the consequential Ub-dependent ER retention/degradation as shown below. These findings are reminiscent of the folding energy-dependent biosynthetic secretion of transthyretin and BSEP (Sekijima et al., 2005) and suggest that proteostatic mechanisms can recognize and eliminate structurally damaged proteins with impaired folding energetics not only in the lumen (Wiseman et al., 2007) , but at the cytoplasmic surface of the ER as well. The in vitro ubiquitination propensities of WT and DF508 NBD1-1S, -3S, and -R1S were assessed following the native NBD1 unfolding at 25 C-50 C for 5 min. Subsequent ubiquitination was performed in the presence of E1 enzyme, UbcH5c (an E2 Ub-conjugating enzyme), CHIP (C-terminal Hsp70-interacting proteins, an E3 Ub-ligase), and ATP (Meacham et al., 2001) for 30 min at 26 C in vitro. Ubiquitination was monitored by the appearance of high molecular mass adducts in anti-NBD1 immunoblots ( Figure 3E ). Half-maximal ubiquitination was achieved at temperatures (T 0.5 ) corresponding to the T m of NBD1-1S and -3S ( Figure 3F ). The unfolding temperature required for 50% ubiquitination was increased proportionally to the DF508-NBD1-R1S stability ( Figure 3F ). This result indicates that the NBD1 conformational defect correlates with the domain ubiquitination propensity that may signal ER degradation. Conformational Stabilization of the DF508-NBD1 Modestly Improves DF508 CFTR Folding As a next step, we assessed whether DF508 CFTR global misfolding can be solely attributed to impaired NBD1 energetics. To this end, CFTR folding behavior was determined as a function of NBD1 thermal stability (T m ) by measuring the conversion of radioactively pulse-labeled core-glycosylated CFTR into complexglycosylated form in BHK cells ( Figure 4A ) . The 1S, 3S, R, or R1S mutations increased the WT CFTR folding efficiency from $27% up to $52% (Figure 4B) . The cellular and PM density of WT CFTR was similarly increased, as evidenced by immunoblotting and cell surface ELISA, respectively, in BHK and COS7 cells (Figures 4C and 4D ). In contrast, stabilization of the DF508-NBD1 only marginally enhanced the mutant folding efficiency (from 0.4% to 3.5%), expression, and PM density (Figures 4A-4D ). These and additional results discussed in the following section show that both folding efficiency and PM density of WT variants increased at $37-and $14-fold steeper slopes, respectively, than their DF508 or F508X counterparts as a function of NBD1 T m ( Figures 5A and 5B) and suggest that NBD1 folding energetics can define the WT but not DF508 CFTR domain-domain assembly. A possible explanation for this phenomenon could be the permissive effect of NBD1-CL4 interface stabilization by the F508 residue for coupled domain folding, an assumption supported by the following results:
(1) Although most missense mutations of the F508 (Q508, S508, D508, and N508) largely preserved the NBD1 thermal stability, monomeric state, secondary structure composition, and TNP-ATP-affinity, they severely compromised CFTR folding (Figures 5A and S4D ; data not shown). Cys and Met substitutions of F508 retained WT CFTR folding conceivably by preserving intra-and interdomain (CL4) side-chain interactions . (2) Although certain combinations of F508N and R or S mutations conferred thermodynamic and kinetic stability comparable with or exceeding that of the WT NBD1-1S (e.g., F508N-R; DG 0 = À5.1 ± 0.1 kcal/mol, T m z47 C and k u H20 = 0.16 10 À3 sec À1 ; Figure S5 ), they failed to restore WT-like folding and expression of the DF508 CFTR ( Figures 5A and 5B ). Similar to the 3S and R4S mutations ( Figures 5A and 5B) , the stabilizing DRI mutation was unable to reinstate WT-like folding and expression in DF508 CFTR ( Figures  4B and 4D) . (3) To demonstrate that the hydrophobic cluster of the NBD1-CL4 interface ( Figure 1B ) stabilizes the CFTR native fold, the conformation of individual domains was probed by limited trypsinolysis in isolated microsomes . The proteolytic fragmentation patterns were visualized by immunoblotting using domain-specific antibodies ( Figure 5C ). The NBD1-, NBD2-, MSD1-, and MSD2-containing fragments, represented by 29-33, 29-31, 35-37, and 53-76 kDa immunoreactive bands, have been validated (Cui et al., 2007; Du et al., 2005) and are indicated by dashed boxes in Figure 5C . Despite the R1S-induced stabilization of the DF508-NBD1, the conformational flexibility of MSD1-, MSD2-, and NBD2-containing fragments could not be reversed, and it remained proteolytically more sensitive than their WT counterparts ( Figure 5C ). This observation implies that correction of the NBD1 energetic defect is insufficient to reinstate domain assembly. Remarkably, NBD1, MSD1, and NBD2 were susceptible to comparable misfolding upon disrupting the NBD1-CL4 interface by the R1070W substitution in WT CFTR. This reduced the channel folding efficiency by $87% ( Figures S6A and 6A-6C) . Conversely, stabilization of the NBD1-CL4 interface by the V510D substitution (see bellow) increased the WT CFTR folding efficiency by $2-fold, supporting the critical role of the NBD1-CL4 interface in the coupled domain folding of CFTR ( Figure 6B ; see below).
Correction of Both DF508-NBD1 Energetics and NBD1-CL4 Interaction Is Required to Synergistically Restore DF508 CFTR Folding and Processing
Because CFTR biogenesis appears to be associated with the formation of the NBD1-CL4 interface Serohijos et al., 2008a) , we tested whether stabilization of the NBD1-CL4
interface alone or in combination with that of NBD1 was also required to increase the DF508 CFTR folding efficiency. R1070W or V510D substitutions at the interfaces restored the proximity of the DF508 NBD1 and CL4 as shown by Cys crosslinking. The NBD1-CL4 interface stabilization can be accomplished by filling the cavity created by the DF508 with the bulky hydrophobic side chain of R1070W or by salt bridge formation between V510D in NBD1 and R1070 in CL4 (Figure S6B ) Loo et al., 2008 Loo et al., , 2010 Thibodeau et al., 2010) . R1070W, similar to V510D, alone modestly increased the DF508 CFTR folding efficiency and cellular and PM expression ( Figures 6A-6E ), in part confirming previous reports Thibodeau et al., 2010; Loo et al., 2010) . In sharp contrast, combining an interface mutation with NBD1 stabilization by 3S, R, or R1S enhanced the DF508 CFTR folding efficiency by 25-to 30-fold and led to 50%-80% of WT CFTR expression in both COS7 and BHK cells ( Figures 6A-6E and S7A ). At the individual domain level, the combination of R1S and R1070W, but not R1S alone, largely restored domain assembly, as indicated by the WT-like trypsin resistance of the MSD1, MSD2, and NBD2 in DF508-CFTR-R1S-R1070W ( Figure 5C ). Similarly, the DF508 CFTR folding and expression were synergistically rescued by combining the DF508-NBD1 stabilizing mutation DRI with R1070W or V510D ( Figures 6F-6H and S7B ), ruling out nonspecific effects of second-site mutations. Direct energetic stabilization of the DF508-NBD1-0S and -3S by the V510D mutation was marginal ( Figure S5 ).
The four-domain minimal folding unit of CFTR (CFTR-1218X) that lacks the NBD2 mimics the cooperative domain folding of WT CFTR (Du and Lukacs, 2009 ). Accordingly, substantially increased folding efficiency of DF508-CFTR-1218X was only achieved by synergistic stabilization of the NBD1-CL4 interface (R1070W or V510D) and NBD1 (3S, -3R, or -R1S) ( Figures 7A-7C , and S7C).
The cooperative domain-folding model predicts that destabilizing NBD1 or the NBD1-CL4 interface would limit the CFTR folding efficiency as reported for several CF-causing mutations in the CLs (Riordan, 2008) . This was indeed the case. CFassociated nonconserved amino acid substitutions (A559E or R600G) that are solvent exposed and distant from the NBD1-CL4 interface prevented the expression of soluble NBD1 in E. coli and CFTR processing in mammalian cells ( Figure S7D ; data not shown). Likewise, disrupting the NBD1-CL4 interface by the R1070W mutation compromised both WT CFTR and CFTR-1218X folding ( Figures 6B, 6C , 6E, left panel, and 7C), as well as the NBD1, NBD2, and MSD1 conformation, which was partly rescued by stabilizing the NBD1 with 3S, R, or R1S ( Figure S6A ). Together, these observations suggest that NBD1-CL4 association results in mutually stabilized NBDs and MSDs. This inference is supported by the partially regained protease (B) PM density of CFTR was measured by cell surface ELISA and plotted as a function of the respective NBD1 T m . Second-site mutations are indicated in the background of F508 (C) or DF508 (B). Symbols are as in (A). Red and blue circles depict the combined effect of R1070W or V5010D interface and 3S, R, or R1S stabilizing mutations on the DF508 CFTR expression. Data are mean ± SEM. (C) Conformational stability of CFTR domains was determined by limited proteolysis. Isolated microsomes expressing CFTR variant were trypsin digested at 4 C for 10 min and probed by domain-specific antibodies. Proteolytic fragments containing NBD1, MSD1, MSD2, or NBD2 are indicated by dashed boxes. See also Figure S6 .
resistance of NBD1, MSD1, and NBD2 ( Figure S6A ) as well as restored folding and processing upon NBD1 stabilization by 3S, R, R1S, or DRI in the CFTR-R1070W and CFTR-1218X-R1070W ( Figures 6B, 6C , 6E, and 7C).
Channel Gating in DF508 CFTR Is Corrected by Interfacial and NBD1-Stabilizing Mutations
Synergistic correction of the DF508 CFTR channel-gating defect could be observed by the interfacial and NBD1-stabilizing Single-channel open probability (P o ) of PKAphosphorylated channels was determined following the reconstitution of CFTR in phospholipid bilayer. The DF508 CFTR P o fold increase is indicated above the bars. The processing defect of the DF508 CFTR variants was rescued at 26 C prior to microsome isolation. Data are mean ± SEM.
(F) Working model of CFTR domain folding and the effect of second-site suppressor mutations on DF508 CFTR coupled domain misassembly. For DF508 CFTR the energetic and topological defect of DF508 NBD1 (D) compromises cooperative domain assembly by disrupting NBD1-MSD2, NBD1-MSD1, and MSD1-MSD2 interfaces (He et al., 2008 Loo et al., 2008; Wang et al., 2007) . The putative folding energy of individual domains is color coded. For DF508+R1S and DF508+R1S+R1070W, although the DF508 NBD1 thermodynamic destabilization can largely be rescued by second-site suppressor mutations (e.g., R1S, 3S, or DRI, indicated as D*), this failed to correct DF508 CFTR misassembly probably due to persistently impaired coupled domain folding. WT-like domain assembly and stabilization of DF508 CFTR were achieved by a combination of NBD1 and NBD1-CL4 interface-stabilizing mutations (e.g., 3S and R1070W or V510D). M2* and red line depict the R1070W mutation. mutation, measured by the open probability of reconstituted and phosphorylated CFTR in a phospholipid planar bilayer (Figure 7D) . The low temperature rescued DF508 CFTR open probability (P o = 0.11 ± 0.01, n = 6) was reduced to 30% of the WT at À60 mV holding potential. The 3S and R1070W mutations increased the DF508 CFTR P o by 27% and 54%, respectively. Combination of the suppressor mutations resulted in a P o (0.28 ± 0.03, n = 8) that was 154% higher than the control (Figure 7E) , indicating that DF508 CFTR functional rescue requires the stabilization of both NBD1 energetics and the NBD1-CL4 interface.
DISCUSSION
The objective of this study was to elucidate the role of NBD1 and the structural consequences of the DF508 mutation in CFTR multidomain assembly. At the isolated domain level, we showed that a combination of thermodynamic and kinetic stability defects is responsible for the DF508 NBD1 misfolding. In full-length CFTR the stability of NBD1 and NBD1-CL4 interface must be maintained for the channel conformational maturation and function. The DF508 impairs both structural prerequisites. In order to achieve domain assembly and function close to that of the WT protein, it is, therefore, essential that energetic and interface defects be corrected simultaneously in the DF508 CFTR.
DF508 Destabilizes the NBD1 Both Thermodynamically and Kinetically
The small difference in the thermal denaturation profile of DF508-NBD1-0S and -1S (T m $32 C and 33 C, respectively) and folding efficiency of CD4T-NBD1-DF508, as well as DF508 CFTR containing 0S or 1S, demonstrate that the 1S mutation marginally reverts the DF508-NBD1 structural defect and justified the use of NBD1-1S as a surrogate domain for NBD1-0S. Thermal and chemical denaturation scans revealed that the DF508 mutation thermodynamically destabilizes the NBD1-0S and -1S at 37 C ( Figures 1D-1G ), in line with recently published data using variable numbers of second-site mutations (Hoelen et al., 2010; Protasevich et al., 2010; Wang et al., 2010) but at variance with earlier findings (Lewis et al., 2005; Qu and Thomas, 1996; Thibodeau et al., 2005) .
The thermodynamics of the NBD1-1S folding profile is profoundly altered by the DF508 mutation. The attenuated (re) folding kinetics of the DF508 NBD1 (Qu and Thomas, 1996; Serohijos et al., 2008b; Thibodeau et al., 2005) could be partly explained by the $4-fold increased folding activation energy (DG f z ) of the isolated DF508 NBD1-1S at 37 C (Figure 2A ). In addition we discovered that DF508 NBD1-1S has $10-fold reduced unfolding activation energy (DG u z ) and a $17-fold faster unfolding rate relative to its WT counterpart at 37 C (Figures 2A,  2D , and S2G). The combination of DF508 NBD1-1S rapid unfolding (T 1/2 $1 s), reduced DG 0 , and impeded folding rate constitutes the complex energetic folding defect and is primarily responsible for DF508 CFTR (Denning et al., 1992) , CD4T-DF508-NBD1, and SUMO-DF508-NBD1-1S misprocessing, as well as for the 2-to 10-fold enhanced NBD1 protease susceptibility in DF508 CFTR (Cui et al., 2007; Du et al., 2005; Roy et al., 2010; Thibodeau et al., 2010) . Energetic stabilization of DF508-NBD1 variants at reduced temperature ( Figure 1E ) also offers a reasonable explanation for the native-like crystal structure of DF508 NBD1-2S and -3S obtained at 4 C-20 C (Lewis et al., 2005 (Lewis et al., , 2010 .
We demonstrated that multiple R and S mutations restore the DF508 NBD1 conformational stability at 37 C (Figures 1 and 2 ) but modestly increase the folding efficiency ( Figure 4B ), expression, and PM function of DF508 CFTR (Pissarra et al., 2008; Teem et al., 1993) . Although some of the R and S mutations are solvent exposed or far from F508, they can stabilize NBD1 through long-range, intradomain interactions among the three NBD1 subdomains with high contact order (Khushoo et al., 2011) , accounting for the structural basis of cooperative NBD1 folding and misfolding. Similar effects were observed in the solvent-exposed W62G mutation of lysozyme that leads to unfolding and fibril formation (Zhou et al., 2007) .
Biophysical characterization also revealed that the WT NBD1-0S and -1S are thermally unstable at 37 C (T m $40 C-42 C). This manifests in the WT SUMO-NBD1and CD4T-NBD1 recognition by the protein quality control machinery in bacteria and mammalian cells, respectively, and the domain ubiquitination in vitro. Although interdomain interactions likely stabilize NBD1 conformationally in WT CFTR, as suggested by the enhanced NBD1 protease susceptibility upon destabilizing the MSD1 or NBD2 by CF-causing point mutation (Cui et al., 2007; Du and Lukacs, 2009; Du et al., 2005; Xiong et al., 1997) , or the NBD1-CL4 interface by R1070W ( Figure S6A ), these stabilizing factors are compromised due to coupled misfolding of MSD1, MSD2, and NBD2 in DF508 CFTR and other mutants (Cui et al., 2007; Du and Lukacs, 2009; Du et al., 2005; Xiong et al., 1997) . Conversely, stabilizing NBD1 by second-site mutations is sufficient to increase WT channel folding efficiency by $2-fold ( Figure S7E ).
Stabilization of Both NBD1 Energetics and Domain
Interface Is a Prerequisite for DF508 CFTR Domain Assembly At least three mechanisms may be responsible for multidomain protein folding: (1) individual domains can fold and function independently, (2) one or more domains can facilitate the folding of the other(s) mutually and/or by acting as a folding template, or (3) the domains(s) can stabilize the folded conformation by interacting in its native state to prevent unfolding. The first scenario has been ruled out (Cui et al., 2007; Du and Lukacs, 2009; Han et al., 2007) . This work provides support for the second and third mechanisms by correlating NBD1 energetics and interface stabilization with CFTR folding efficiency and domain conformation.
(1) Here, we showed that both NBD1 and the NBD1-CL4 interface instability contribute to the intrinsically lowfolding efficiency of the WT CFTR in vivo (Riordan, 2008) . S, R, or DRI mutations increased the WT channel folding efficiency (by 20%-80%) in proportion with NBD1 stabilization, a tendency that is also observed in the background of NBD1-CL4 destabilization in R1070W-CFTR ( Figures 4B and 6B) . Stabilization of the NBD1-CL4 interface by salt bridge formation between V510D and R1070 also improved WT CFTR biogenesis ( Figure 6B ).
Although protease susceptibility and FRET measurements suggest that NBD1 undergoes cotranslational folding Khushoo et al., 2011) , it is likely that NBD1 and interface stabilization can facilitate CFTR folding by favorably influencing the folding thermodynamics and/or kinetics of interacting domains. This mechanism would be consistent with the lack of measurable difference in the NBD1 protease susceptibility when comparing WT and WT-3S CFTR (data not shown) and increased folding efficiency of DF508 CFTR upon blocking ER-associated ubiquitination in the presence of corrector molecules (Grove et al., 2009) . (2) Cysteine-crosslinking studies have demonstrated that NBD1 S mutations (e.g., 3S) restored the NBD1-CL4 and NBD2-CL2 (MSD1) association . Intriguingly, the proximity of selectively crosslinked interface residues is insufficient to profoundly enhance DF508 CFTR and CFTR-1218X folding, presumably due to transient interactions of the domains ( Figures 4B, 5C , and 6A-6C). Accordingly, pharmacological chaperones (e.g., RDR1, a substituted phenylhydrazone) and second-site suppressor mutations used here ( Figure 5A ) and elsewhere Hoelen et al., 2010; Sampson et al., 2011) failed to restore DF508 CFTR folding, despite reverting DF508-NBD1 stability nearly to that of the WT domain. The combination of NBD1 and NBD1-CL4 interface stabilization, however, led to robust biochemical and functional rescue, as well as the acquisition of protease resistance in MSD1, MSD2, and NBD2 (Figures 5, 6, and 7E) . This last observation suggests that stabilization of MSD2 and MSD1 by NBD1 interactions is indispensable for the conformational rescue of the NBD2 and DF508 CFTR.
Based on the three-dimensional architecture and cooperative folding model of CFTR as well as the energetic and topological defect of the DF508 NBD1, it is reasonable to speculate that the channel structure destabilization is initiated by the compromised NBD1-CL1 interface (He et al., 2008) . This view is consistent with the increased metabolic turnover of the MSD1-NBD1-R caused by DF508 (Rosser et al., 2008) (Figure 7F ). MSD2 translation further exacerbates the tertiary structural defect due to the disruption of the NBD1-CL4 hydrophobic cluster and consequential destabilization of the MSD2 and MSD1-MSD2 packing (Cui et al., 2007; Du and Lukacs, 2009; Wang et al., 2007) . This in turn compromises the NBD2-CL2/CL3 and NBD1-NBD2 interfaces, culminating in the global misfolding of NBD2 and DF508 CFTR (Cui et al., 2007; Du et al., 2005) (Figure 7F ). This multistep misfolding can be modulated by cytosolic chaperones Rosser et al., 2008; Wang et al., 2006) and by strategically placed second-site suppressor mutations that may also be mimicked by small molecule correctors.
Implications for Correcting CF and Other Conformational Diseases Caused by Multidomain Membrane Protein Misfolding
Conformational stabilization of mutant polypeptides with energetically compromised but partially preserved ligand-binding capacity has been achieved by pharmacological chaperones to restore their biosynthetic processing (Bernier et al., 2004) . The combination of impaired energetics and domain interactions of DF508 NBD1 provides a reasonable explanation for the limited rescue efficiency (<15%) of DF508 CFTR by individual corrector molecules isolated in HTSs of chemical libraries (Clancy et al., 2011; Van Goor et al., 2011; Wang et al., 2007) . Our results suggest a rational, structure-based screening strategy to isolate combinations of corrector molecules that may preferentially stabilize the mutant NBD1 and the NBD1-CL4 interface.
At a more general level, our results highlight the potential consequence of destabilizing interface mutations in cooperatively folding multidomain membrane proteins and demonstrate that folding of neighboring domains can be compromised by interface mutations similar to a subset of multidomain soluble polypeptides (Han et al., 2007) . Extension of this paradigm to multidomain PM proteins may serve as a framework in future studies of folding diseases caused by mutations clustered at domain interfaces, as in the case of the shaker CLC and ABCC6 transporter (Feng et al., 2010; Fü lö p et al., 2009 ).
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of CFTR and NBD1 Proteins Point mutations were introduced into WT and DF508 CFTR-3HA cDNA by overlapping PCR mutagenesis as described before . CD4T-NBD1 expression constructs were generated by inserting PCR-amplified NBD1 cDNAs into the XmaI/ApaI sites of pcDNA3-CD4T (Du and Lukacs, 2009) .
The pET26b-derived expression vectors with N-terminal His 6 -SUMO fusion tag containing the human WT or DF508 NBD1-3S and -R4S with the crystallization domain boundaries were kindly provided by H. Lewis (Structural GenomiX and CFFT) and C. Lima (Columbia University) and purified as described (Lewis et al., 2005) .
Circular Dichroism and Fluorescence Spectroscopy
Circular dichroism (CD) spectroscopy was performed using a Chirascan CD spectrometer (Applied Photophysics, Leatherhead, UK). CD scans were collected on proteins in 150 mM NaCl, 1 mM ATP, 3 mM MgCl 2 , and 50 mM sodium phosphate buffer at pH 7.5 between 260 and 190 nm at 20 C or 25 C using a 0.2 mm path-length cuvette at $14 mM NBD1 concentration.
CD measurements were acquired every 0.5 nm with 0.5 s as an integration time and repeated three times with baseline correction. Thermal unfolding scans were measured at 208 nm with a 0.5 C step size at 1 C/min ramp rate with ± 0.1 C tolerance.
Tryptophan fluorescence of NBD1 (12 mM in a 1 mM ATP, 3 mM MgCl 2 , 150 mM NaCl, and 10 mM HEPES at pH 7.5) during thermal unfolding was monitored using a Cary Eclipse spectrofluorometer (Varian, Palo Alto, CA, USA) with a 3 3 3 mm micro-quartz cuvette. Fluorescence emission was monitored at 340/350 nm at 290 nm excitation wavelengths at 300 nm/min scan rate. The data were fitted to a Boltzmann sigmoid function to calculate the T m using the Excel add-on package XLfit (IDBS, Bridgewater, NJ, USA) as described (Senisterra et al., 2008) . DSF DSF of NBD1 (7-12 mM) scans was obtained routinely in 150 mM NaCl, 20 mM MgCl 2 , 10 mM HEPES, and 2.5 mM ATP at pH 7.5 in the presence of 23 Sypro Orange or Nano Orange, using a Stratagene Mx3005p (Agilent Technologies, La Jolla, CA, USA) qPCR instrument (Lo et al., 2004; Niesen et al., 2007 
